S9 Ep37: Naumann Discusses Notable Research Efforts in Endometrial Cancer
Dr Naumann discusses the role of frontline maintenance therapy for patients with endometrial cancer; which patients are likely to benefit from the RUBY and NRG-GY018 trial regimens; and ongoing research that may elucidate optimal treatments for patients with recurrent, dMMR disease.
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.